Dorzolamide and Timolol - Uses, Dosage, and Side Effects

Overview

Treating high intraocular pressure (IOP) linked to ocular hypertension and open-angle glaucoma, Dorzolamide is a topical carbonic anhydrase (CA) inhibitor and non-bacteriostatic sulfonamide derivative. It prevents an enzyme in the ciliary mechanism, which controls the eyes' ion balance and fluid pressure. In contrast to oral CA inhibitors, Dorzolamide has very little effect on electrolyte or acid-base imbalances and other systemic side effects. Dorzolamide, first commercialized in 1995, is sold as monotherapy or in combination with Timolol.

For Patients:

Two medications (Dorzolamide and Timolol) are included in this product to treat ocular hypertension, open-angle glaucoma, and other eye conditions causing elevated intraocular pressure. Reduced intraocular pressure aids in the prevention of blindness. This drug acts by reducing the volume of fluid in the eye. Timolol is a member of the beta-blocker drug class, while Dorzolamide is a member of the carbonic anhydrase inhibitor drug class.

How to Use Drops of Dorzolamide or Timolol?

Before beginning the use of Dorzolamide or Timolol, each time one receives a refill, read the patient information leaflet, if one is available from the chemist. See the physician or chemist if one has any questions. Follow the doctor's instructions and apply this medication to the affected eye or eyes, usually one drop twice daily.

Before using eye drops, wash hands. Do not touch the dropper tip or allow it to come into contact with the eyes or any other surface to prevent infection. Contact lenses have the potential to absorb preservatives included in some items. Remove the contact lenses if one is using a product with preservatives and before applying the eye drops. Before inserting the contact lenses, wait at least fifteen minutes. To make space, tilt the head back, lift the gaze upward, and pull down the lower eyelid. One drop should be inserted into the eye as one holds the dropper straight over it. For a minute or two, look down and gradually close the eyes. Press with one finger in the inner corner of the eye, close to the nose. Avoid blinking and rubbing eyes. This will stop the drug from running out. If instructed, repeat similar actions with the other eye.

Keep the dropper dry. Following every usage, replace the drip cap. Allow at least five minutes before administering further eye medications, such as drops or ointments. To allow eye drops to reach the eye, apply them before applying ointments. To reap the greatest benefits from this drug, use it frequently. Utilize it at the same time each day.

What Are the Adverse Reactions Related to Dorzolamide or Timolol?

Temporary symptoms may include

• Headaches.

• Watery or dry eyes.

• Burning.

• Stinging.

• Itching.

• Redness in the eyes.

• Sensation as though something is in the eyes.

• Sensitivity to light.

• Unusual tastes in the mouth or eyes.

Notify the chemist or doctor immediately if these side effects persist or worsen. Recall that the doctor has prescribed this medication because they believe it will benefit one more than it will cause adverse side effects. Many users of this medicine report no significant adverse effects. If one has any severe side effects, such as:

• Dizziness.

• Slow or irregular heartbeat.

• Muscle weakness.

• Changes in the mental or emotional state.

• Coldness.

• Numbness.

• Pain in the hands or feet, changes in the vision.

• Symptoms indicative of a kidney stone (such as back, side, or abdomen pain, nausea, vomiting, or blood in the urine).

• Yellowing of the eyes or skin.

• Dark urine.

• Unusual weakness or fatigue.

• Easy bruising, bleeding, or infection-related symptoms (chills, fever, or persistent sore throat).

If one has any extremely significant side effects, such as

• Persistent eye redness or discharge.

• Swelling of the eye or eyelids.

• Pain in the eyes.

• Rapid unexplained weight gain.

• Chest pain.

• Weakness on one side of the body.

• Difficulty speaking.

• Confusion.

• Extreme dizziness.

• Fainting.

Get medical attention at once. Rarely, this medication may cause hazardous adverse reactions. However, if one has any of the following signs of a significant allergic response, immediately obtain medical attention:

• Rash.

• Breathing difficulties.

• Extreme dizziness.

• Itching.

• Swelling, especially in the face.

• Tongue.

• Neck.

What Are the Precautions While Using This Medication?

Inform the doctor or chemist if one has allergies before using Timolol Or Dorzolamide or other medical conditions. Preservatives like benzalkonium chloride, inactive chemicals in this product, may trigger allergic reactions or other issues. For further information, consult the chemist.

Before using this medication, please discuss all the medical history with the doctor or pharmacist.

• In particular, mention any lung conditions one may have, such as asthma or chronic obstructive pulmonary disease.

• Irregular heartbeats, such as sinus bradycardia or second or third-degree AV block, and heart failure.

• Kidney disease, including kidney stones.

• Liver disease.

• Diabetes.

• Overactive thyroid disease.

• Disorders causing muscle weakness.

• Low blood flow to the brain (cerebrovascular insufficient).

What Are the Drug Interactions?

• It might alter the way the prescriptions function or raise the possibility of experiencing severe side effects. Not all potential medication interactions are covered in this document. Make a list of everything one uses, including over-the-counter and prescription medications and herbal remedies, and provide it to the chemist and physician. Before beginning, stopping, or altering the amount of any medication, get the doctor's approval.

• High dosages of Aspirin or related salicylates, oral beta-blockers (like Propranolol), oral carbonic anhydrase inhibitors (like Acetazolamide and Methazolamide), clonidine, some antidepressants (including SSRIs like Fluoxetine), Digoxin, Epinephrine, Methyldopa, and Quinidine are some products that may interact with this medication.

• Low-dose Aspirin, as directed by the physician for particular medical conditions, such as preventing a heart attack or stroke.

What Unfavorable Consequences Might This Drug Have?

Timolol and Dorzolamide have potential adverse effects. Inform the physician if any of these symptoms are severe or persistent:

• Taste shifts (unusual, sour, or bitter flavor).

• Burnt or stung my eyes.

• Eyes that itchy.

• Desiccated eyes.

• Tearful eyes.

• Vertigo.

Some adverse effects may be severe. Contact the doctor immediately if one encounters any of the following symptoms:

• Vision distortion.

• Skin rash.

• Edema in the lower limbs, hands, feet, or ankles.

• Breathing difficulties.

• Blue eye.

• Inflammation or redness on the eyelid.

• Weakened muscles.

Timolol and Dorzolamide could bring on other adverse effects. If one encounters any strange side effects while taking this medication, give the doctor a call.

For Doctors:

Significance

In individuals suffering from open-angle glaucoma or ocular hypertension, Dorzolamide is recommended for the treatment of increased intraocular pressure. For the same purpose, it can also be used with Timolol in patients who do not respond well to ophthalmic beta-blockers. Its pre-operative use was also studied to avoid increased intraocular pressure following neodymium yttrium aluminum garnet laser posterior capsulotomy.

• Lower the failure rates of medication development.

• Create, hone, and verify machine learning models.

• Using structured and evidence-based datasets.

Concurrent Conditions

• Increased IOP (intraocular pressure).

• Eye hypertension.

Pharmacodynamics:

A carbonic anhydrase inhibitor called Dorzolamide lowers increased intraocular pressure in cases of ocular hypertension or open-angle glaucoma. Using Dorzolamide with topic beta-adrenergic antagonists together reduces intraocular pressure additively. Dorzolamide's maximum ocular hypotensive impact is noticeable around two hours after topical application.

Mechanism Of Action:

One of the hallmarks of open-angle glaucoma or ocular hypertension is elevated intraocular pressure. The balance between the ocular ciliary processes' production of aqueous humor and its outflow from the anterior portion of the eye through either the standard trabecular pathway or the unconventional uveoscleral pathway controls the intraocular pressure (IOP) level. The intraocular pressure rises when there is a greater barrier to the trabecular outflow of aqueous humor. Consequently, ocular structure mechanical distortion and blood flow constraints may cause damage to the optic nerve. Optic disc cupping and progressive visual field loss (and blindness in many circumstances) are additional consequences of optic nerve injury.

One common enzyme that catalyzes the reversible hydration of carbon dioxide to bicarbonate ions and the dehydration of carbonic acid is called carbonic anhydrase (CA). The local bicarbonate generation of CAs in the ocular ciliary processes facilitates sodium and fluid transfer. One important isoenzyme that controls the generation of aqueous humor is CA-II, which is primarily present in Red Blood Cells (RBCs). As a highly selective inhibitor of CA-II, Dorzolamide exhibits an affinity for carbonic anhydrase II that is 4000-fold greater than that of carbonic anhydrase I. Aqueous humor secretion and intraocular pressure are both lowered when CA-II in the ciliary process is inhibited. This is because it interferes with the production of bicarbonate ions and decreases sodium and fluid transport.

Absorption:

In trials on animals, Dorzolamide entered the eye with ease. Dorzolamide is absorbed by the cornea and stroma when administered topically. It has been found that Dorzolamide is absorbed systematically after topical application. After receiving an oral dose of 2 mg Dorzolamide twice a day (corresponding to an ocular dose of two percent dorzolamide three times daily), healthy volunteers were evaluated for their systemic exposure to Dorzolamide after long-term administration. After receiving the medication for 20 weeks, the individuals attained a steady state in 8 weeks.

Volume of Distribution:

The plasma concentrations of Dorzolamide and its primary metabolite are typically below the test limit of quantification, which is 15 nM, notwithstanding the paucity of information regarding the drug's distribution volume. After being administered chronically, Dorzolamide binds to CA-II, which is present in peripheral red blood cells (RBCs), causing it to accumulate in red blood cells.

Proteins Binding:

About 33 % of Dozolamide is bound to plasma proteins.

Metabolic Process:

N-desethyldorzolamide, which is produced by a delayed metabolism of Dorzolamide, has some inhibitory effects on CA-II but less pharmacological action on CA-II. N-desethyldorzolamide binds to CA-I in RBCs, where it is likewise preserved, much like the parent medication. The results of an in vitro investigation employing rat liver microsomes indicate that CYP2B1, CYP2E1, and CYP3A2 are involved in the metabolism of Dorzolamide the rat liver.

Elimination:

N-desethyldorzolamide is also found in the urine. However, Dorzolamide is mostly eliminated unaltered through the urine.

Half-life:

Dorzolamide, kept in red blood cells, is eliminated from them non-linearly after the drug is withdrawn, with a terminal elimination half-life of around 120 days. The slow elimination phase, where the medication's elimination half-life is roughly less than four months, comes after the first fast drop in drug concentrations.

Clearance Rates:

The clearance rate of Dorzolamide needs to be better understood.

Negative Impacts:

Dorzolamide's oral LD50 in rats is 1927 mg/kg, whereas in mice, it is 1320 mg/kg. In both rats and mice, the subcutaneous LD50 is greater than 2 g/kg. Acidosis, electrolyte imbalance, and perhaps effects on the central nervous system can all be caused by overdosing; appropriate supportive care should be given to address these symptoms. It is recommended that in the event of a suspected overdose, the patient's blood pH and serum electrolyte (especially potassium) levels be closely watched.

Before Using:

One must consider the potential hazards and benefits when choosing which medication to take. The doctor and one will decide on this. When using this medication, keep the following in mind:

• Intolerants: Let the doctor know if one has ever experienced an unexpected or adverse reaction to this medication or any other medication. Inform the healthcare provider about any additional allergies one may have, including those to foods, colors, preservatives, or animals. Carefully review the ingredients listed on the label or container of non-prescription products.

• Children: The appropriate research conducted thus far has not revealed any pediatric-specific issues that would restrict the effectiveness of Timolol and Dorzolamide eye drops in children two years of age and older. Nevertheless, no evidence of safety or effectiveness has been found in children under two.

• Senior Care: The results of the studies conducted thus far have not revealed any issues unique to the elderly that would restrict the individual’s ability to benefit from Dorzolamide and Timolol eye drops.

• Pregnancy: There is not enough research on women to determine the harm to the baby of taking this medicine while breastfeeding; however, if nursing, weigh the possible advantages against the potential disadvantages before starting the drug.

Drug-Interaction Relations:

While some medications should never be combined, there are other situations in which two distinct medications can be taken together, even though there may be an interaction. The doctor might wish to adjust the dosage or suggest taking other safety measures in certain situations. While it is generally not advised, using this medication with any of the following medications might be necessary in specific circumstances. Should the doctor administer both medications concurrently, they may adjust the dosage or frequency of one or both doses.

• Abiraterone Acetate.

• Aspartame.

• Aspirin.

• Propranol.

• Quintinib.

• Synthroid.

• Dualistat.

• Zinc oxide.

• Divalproexine.

• Bitartiazem.

• Levicoxetine.

• Adrenaline.

• Rectaloprodam.

• Federratib.

• Meloxicam.

• Tongolimod.

• Osteoterol.

• Adecaterol.

• Levabotrimer.

• Menthol.

• Metformin.

There may be a higher chance of specific side effects if one uses this medication with any of the other medications, but taking both may be the best course of action for one. If the doctor prescribes both medications at the same time, they might alter the dosage.

Other Health Issues:

The existence of additional medical issues may impact the use of this medication. Make sure the physician is aware of any additional health issues one may have, particularly:

The use of Timolol and Dorzolamide eye drops in patients with acute angle-closure glaucoma has yet to be researched. Dorzolamide alone may not be the only medication or treatment needed for this problem.

• Allergies Like Sulfonamide Allergy - The severity and length of allergic reactions to other chemicals may be enhanced. Examples of such medications include antibiotics and stomach pills, such as Sulfamethoxazole, Sulfasalazine, and Sulfisoxazole.

• Asthma.

• Abnormally slow heartbeat or bradycardia.

• Cardiac arrest-related shock, also known as cardiogenic shock.

• Severe or persistent chronic obstructive pulmonary disease (COPD).

• Cardiac arrest.

• Heart failure patients with certain diseases should not use this medication.

• Bacterial infection of the eyes (such as keratitis).

• Issues with the cornea (a portion of the eye).

• Recent eye surgery.

• Diabetes.

• Overactive thyroid or hyperthyroidism.

• Low blood sugar, or hypoglycemia, can mask some of these diseases' warning signs and symptoms, like a rapid heartbeat.

• Kidney disease.

• Liver illness is removed from the body more slowly; the effects could be amplified.

• Severe muscle illness, or myasthenia gravis, may exacerbate symptoms like muscle weakness.

Conclusion:

Glaucoma and other disorders with elevated intraocular pressure are treated with Dorzolamide and Timolol. It reduces the volume of fluid within the eye, which aids in lowering intraocular pressure. It combines the effects of a beta blocker and an inhibitor of carbonic anhydrase. One can ask the chemist or healthcare professional if one has any queries about the possible uses of this medication.